Parnax Lab Ltd

Parnax Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Parnax Lab Ltd

₹ 130 2.20%
12 Jun - close price
naxparlab.com BSE: 506128
About

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Key Points

Business Overview:[1][2]
PLL is a part Naxpar Group and is a WHO-approved and EHS-compliant Company. It is into contract manufacturing of Liquid Orals, Capsules, Ointments, External Powders & Tablets with its manufacturing facility located
at Silvassa.

Website BSE
  • Market Cap ₹ 149 Cr.
  • Current Price ₹ 130
  • High / Low ₹ 182 / 96.2
  • Stock P/E 11.7
  • Book Value ₹ 82.8
  • Dividend Yield 0.00 %
  • ROCE 13.9 %
  • ROE 14.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
40.91 48.74 42.61 50.99 46.37 50.12 48.36 40.22 49.04 53.38 62.60 62.94 69.63
36.18 42.24 37.32 45.02 40.58 41.50 41.12 35.95 42.41 45.94 54.52 56.09 64.75
Operating Profit 4.73 6.50 5.29 5.97 5.79 8.62 7.24 4.27 6.63 7.44 8.08 6.85 4.88
OPM % 11.56% 13.34% 12.41% 11.71% 12.49% 17.20% 14.97% 10.62% 13.52% 13.94% 12.91% 10.88% 7.01%
0.27 0.24 0.22 0.10 0.25 0.11 0.95 0.19 0.43 0.18 0.63 -0.17 1.76
Interest 1.18 1.16 1.43 1.35 1.41 1.50 1.38 1.23 1.28 1.22 1.40 1.47 1.61
Depreciation 1.59 1.60 1.74 1.78 1.84 1.83 1.94 1.79 1.83 1.94 2.10 1.96 2.04
Profit before tax 2.23 3.98 2.34 2.94 2.79 5.40 4.87 1.44 3.95 4.46 5.21 3.25 2.99
Tax % 35.43% 16.33% 20.09% 25.85% 19.35% 26.30% 29.77% 16.67% 26.08% 26.46% 30.33% 16.62% 27.09%
1.44 3.33 1.87 2.18 2.24 3.99 3.42 1.21 2.93 3.28 3.62 2.71 2.19
EPS in Rs 1.25 2.89 1.63 1.90 1.95 3.47 2.97 1.05 2.54 2.85 3.16 2.36 1.90
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
103 71 95 106 109 95 90 163 168 189 188 249
91 61 82 95 99 89 80 140 145 165 161 221
Operating Profit 12 10 13 10 10 6 10 23 23 24 27 27
OPM % 12% 14% 14% 10% 9% 7% 11% 14% 14% 12% 14% 11%
1 1 0 1 2 1 0 0 1 1 1 2
Interest 4 4 5 4 4 5 5 5 5 5 5 6
Depreciation 3 3 4 4 4 4 5 6 7 7 7 8
Profit before tax 5 3 5 3 5 -2 -0 12 12 12 16 16
Tax % 22% 28% 22% 65% 28% 48% 350% 33% 30% 20% 26% 26%
4 3 4 1 3 -3 -0 8 9 10 12 12
EPS in Rs 5.01 2.95 4.33 1.23 3.88 -3.42 -0.42 8.40 7.51 8.37 10.03 10.26
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 23%
3 Years: 14%
TTM: 32%
Compounded Profit Growth
10 Years: 18%
5 Years: 105%
3 Years: 14%
TTM: 9%
Stock Price CAGR
10 Years: 15%
5 Years: 36%
3 Years: 28%
1 Year: 20%
Return on Equity
10 Years: 11%
5 Years: 15%
3 Years: 15%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8 8 8 8 8 8 8 10 11 11 11 11
Reserves 17 19 23 24 27 24 24 38 51 60 72 84
41 42 39 37 42 51 59 69 55 81 70 83
17 10 15 18 17 23 15 36 28 38 37 50
Total Liabilities 83 79 86 87 95 107 106 153 145 190 190 228
36 38 47 44 51 58 60 72 77 89 88 115
CWIP 1 2 0 0 0 3 5 3 2 21 29 11
Investments 1 1 0 0 0 0 0 0 0 0 0 0
45 38 38 43 43 46 41 78 66 80 72 101
Total Assets 83 79 86 87 95 107 106 153 145 190 190 228

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0 3 16 13 9 9 6 9 21 16 32 8
-4 -6 -10 -5 -11 -13 -7 -16 -10 -32 -16 -16
6 1 -5 -7 1 5 0 12 -14 15 -16 8
Net Cash Flow 1 -2 0 1 -1 0 -0 4 -3 -1 0 -0
Free Cash Flow -4 -3 5 8 -3 -4 -0 -8 11 -16 16 -9
CFO/OP 15% 46% 134% 134% 99% 153% 71% 38% 103% 79% 130% 42%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 84 100 72 65 64 88 68 85 61 63 60 56
Inventory Days 38 64 50 45 52 76 80 73 79 94 87 90
Days Payable 51 30 48 45 44 74 46 81 53 74 72 80
Cash Conversion Cycle 71 134 74 64 72 90 102 77 86 83 75 65
Working Capital Days 16 7 -26 -8 0 -31 -66 -35 -19 -23 -24 -11
ROCE % 16% 11% 14% 11% 12% 3% 6% 17% 15% 13% 14% 14%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Capital Work in Progress (CWIP)
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Freight & Octroi (Export & Outward) - Standalone
INR Lakhs ・Standalone data
Number of Permanent Employees
Number ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30%
27.69% 27.69% 27.70% 27.70% 27.70% 27.71% 27.71% 27.70% 27.70% 27.71% 27.70% 27.71%
No. of Shareholders 3,2213,5433,5364,4964,4064,1734,5214,4404,3174,1113,9003,721

Documents

Announcements

Annual reports

Credit ratings